Overview

Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine whether duloxetine can help subjects with stress urinary incontinence and to see whether the effects of duloxetine can be maintained.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride